Stay Up to Date on the Latest News and Events from SLW
China’s Supreme People’s Court Issues Guidelines for Ascertaining Technical Facts in Cases Involving New Plant Varieties
On June 9, 2026, China’s Supreme People’s Court issued the Guidelines for Ascertaining Technical Facts in Cases Involving New Plant Varieties (人民法院审理植物新品种案件技术事实查明工作指引) (the “Guidelines”). The Guidelines represent the first dedicated instrument governing the ascertainment of technical facts in plant variety rights litigation in China, and were promulgated pursuant to the Civil Procedure Law of the […]
China’s National Intellectual Property Administration Publishes 2026 Plan for Building a Strong Intellectual Property Nation
On May 16, 2026, China’s National Intellectual Property Administration (CNIPA) published the 2026 Plan for Building a Strong Intellectual Property Nation (2026年知识产权强国建设推进计划). The Plan is an annual implementation document released by the Office of the Inter-Ministerial Joint Conference on Building a Strong Intellectual Property Nation. It operationalizes the longer-term Outline for Building a Strong Intellectual […]
China’s National Medical Products Administration Releases Interpretation of the “Implementation Measures for the Measures for Drug Trial Data Protection”
In follow up to the May 15, 2026 release of the Implementation Measures for the Measures for Drug Trial Data Protection (药品试验数据保护实施办法), China’s National Medical Products Administration also released an Interpretation of the same. The Interpretation provides more details the Measures, such as what is test data used to prove the safety, efficacy and quality […]
China’s National Medical Products Administration Releases Implementation Measures for Drug Trial Data Protection – May 30, 2026 Submission Deadline!
On May 15, 2026, China’s National Medical Products Administration (NMPA) released the Implementation Measures for Drug Trial Data Protection (药品试验数据保护实施办法), effective May 15, 2026. The Measures provide equal drug trial data protection terms for domestic and foreign-developed drugs. The data protection scope includes all test data used in the drug marketing authorization application to demonstrate […]
China’s 2026 Legislative Work Plan – Trademark Law Not Included
On May 11, 2026, China’s Standing Committee of the National People’s Congress released their 2026 Legislative Work Plan (国务院2026年度立法工作计划). Of note, the Trademark Law is not in the Plan despite the draft released for comment in December 2025. Of interest in the Plan though are: Regulations of the People’s Republic of China on Combating Undue […]
Punitive Damages, Plant Varieties, and FRAND: Highlights from China’s 2025 IP Status White Paper
On May 7, 2026, China’s National Intellectual Property Administration (CNIPA) released a white paper entitled “China’s Intellectual Property Protection Status in 2025” (二〇二五年中国知识产权保护状况). The white paper documents developments across judicial protection, administrative enforcement, legislative reform, international cooperation, and public services during the final year of China’s 14th Five-Year Plan period. Overall Indicators China’s IP protection […]